Erythema multiforme: As a complication of allergen-specific immunotherapy.
Here we present a 25-year-old female patient admitted with a complaint of blistering lesions on her face, neck, chest and extremities appearing after the first dosis of specific immunotherapy and diagnosed as erythema multiforme. To our knowledge, there are no papers in the literature reporting erythema multiforme due to specific immunotherapy.
Karakaya
G
G
Adult Allergy Unit, Hacettepe University Hospital, Department of Chest Diseases, Ankara, Turkey. gkarakay@hacettepe.edu.tr
Sahin
S
S
Fuat Kalyoncu
A
A
D000328:Adult; D000485:Allergens / Q000009:adverse effects* / Q000627:therapeutic use; D000818:Animals; D039741:Antigens, Dermatophagoides; D000946:Antigens, Fungal / Q000009:adverse effects* / Q000627:therapeutic use; D003888:Desensitization, Immunologic / Q000009:adverse effects*; D004892:Erythema Multiforme / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D005658:Fungi / Q000276:immunology; D006023:Glycoproteins / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008925:Mites / Q000276:immunology; D011239:Prednisolone / Q000627:therapeutic use; D012221:Rhinitis, Allergic, Perennial / Q000628:therapy
D000485:Allergens; D039741:Antigens, Dermatophagoides; D000946:Antigens, Fungal; D006023:Glycoproteins; D007166:Immunosuppressive Agents; D011239:Prednisolone